Open AccessSafety and efficacy of tislelizumab plus chemotherapy for first‐line treatment of advanced esophageal squamous cell carcinoma and gastric/gastroesophageal junction adenocarcinoma
Author(s) -
Qiu HaiBo
Publication year - 2020
Publication title -
thoracic cancer
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.823
H-Index - 28
eISSN - 1759-7714
pISSN - 1759-7706
DOI - 10.1111/1759-7714.13690
Subject(s) - medicine , pembrolizumab , chemotherapy , oncology , cancer , regimen , adenocarcinoma , esophageal cancer , immunotherapy , cisplatin